NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Clinical Gastroenterology and Hepatology · 2024-01 · 22 (1) · 197-199.e3
DOI: 10.1016/j.cgh.2023.05.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-01. Verfasst von Jia Hong Koh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Non-alcoholic Fatty Liver Disease, Liver Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death globally.The burden of nonalcoholic steatohepatitis (NASH) and alcohol-related HCC has increased substantially over the last decade.1,2 In previous studies, NASH was determined to be the fastest-rising cause of HCC in liver transplant candidates in the United States, although chronic hepatitis C (CHC) remained the leading cause.3,4 However, the latest etiologic trends among waitlisted candidates in the United States are unclear.Hence, using PROCARP national registry data from the United Network for Organ Sharing database
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore.
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore. Electronic address: chenhanng@gmail.com.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- NAFLD Research Center, University of California at San Diego, San Diego, California.
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; NAFLD Research Center, Universi…
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- NIEHS NIH HHS
- NIAAA NIH HHS
- NHLBI NIH HHS
- National Institute of Environmental Health Sciences
- National Center for Advancing Translational Sciences
- U.S. Department of Defense
Zitieren
APA
Koh, J. H., Ng, C. H., Nah, B., Tan, D. J. H., Loomba, R., Huang, D. Q., & Nash HCC Transplant Collaborative (2024). NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clinical Gastroenterology and Hepatology, 22(1), 197-199.e3. https://doi.org/10.1016/j.cgh.2023.05.019
Vancouver
Koh JH, Ng CH, Nah B, Tan DJH, Loomba R, Huang DQ, et al. NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clinical Gastroenterology and Hepatology. 2024;22(1):197-199.e3. doi:10.1016/j.cgh.2023.05.019
BibTeX
@article{Koh2024,
author = {Koh, Jia Hong and Ng, Cheng Han and Nah, Benjamin and Tan, Darren Jun Hao and Loomba, Rohit and Huang, Daniel Q and Nash HCC Transplant Collaborative, Nash HCC Transplant Collaborative},
title = {NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
volume = {22},
number = {1},
pages = {197--199.e3},
doi = {10.1016/j.cgh.2023.05.019}
}
EUVIMED